首页 > 市场调查报告书 > 医疗设备

止血剂和组织密封剂市场规模、份额和成长分析（按产品、材料、应用、最终用途和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900369

止血剂和组织密封剂市场规模、份额和成长分析（按产品、材料、应用、最终用途和地区划分）－2026-2033年产业预测

Hemostasis and Tissue Sealing Agents Market Size, Share, and Growth Analysis, By Product (Topical Hemostats, Adhesive & Tissue Sealant), By Material, By Application, By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球止血和组织密封剂市场规模预计在 2024 年达到 80.1 亿美元，从 2025 年的 86.6 亿美元增长到 2033 年的 161.5 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.1%。

受慢性病增多和人口老化导致的手术需求上升的推动，全球止血剂和组织黏合剂市场正经历强劲成长。这种不断增长的需求促使人们寻求能够提高患者安全并最大限度减少併发症的高效止血和黏合解决方案。外科手术技术的创新，尤其是微创技术的进步，进一步推动了市场扩张，因为患者越来越依赖可靠的药物来获得最终疗效。製造商正优先投入研发，开发疗效更佳、副作用更小的先进产品，以提高其在医疗专业人员中的认可度。然而，严格的法规结构、成本限制和竞争压力等挑战仍然影响着市场动态和盈利，因此需要持续投资于创新和策略定位。

全球止血剂和组织密封剂市场驱动因素

微创手术技术的日益普及显着增加了对专用止血剂和组织封装的需求，尤其是在腹腔镜、内视镜和机器人辅助手术中。这些药物对于有效止血和确保组织牢固闭合至关重要，有助于改善手术效果和促进患者康復。随着医疗专业人员不断采用这些先进的手术技术，对辅助手术的创新解决方案的需求也在不断增长，从而推动了止血剂和组织黏合剂市场的发展。这一趋势反映了现代医学中提高手术效率和病人安全性的更广泛追求。

限制全球止血剂和组织黏合剂市场的因素

新型止血剂和组织黏合剂的市场准入往往受到漫长而高成本的核准流程的阻碍，这主要是由于严格的监管要求。这些严格的通讯协定为生产商带来了巨大的挑战，并延缓了创新产品的商业化。因此，新型产品更难通过复杂的监管程序并获得市场认可，最终抑制了竞争，限制了医疗服务提供者和患者的选择。这可能会对全球止血剂和组织黏合剂市场的整体成长产生负面影响。

全球止血剂和组织密封剂市场趋势

全球止血和组织黏合剂市场正日益受到微创手术技术显着发展的推动。这一趋势源自于微创手术的许多优势，例如切口更小、疤痕更少、恢復更快。随着医疗专业人员采用这些先进技术，对专业止血和组织密封解决方案的需求爆炸性增长，从而推动了产品研发的创新。对患者疗效的日益关注，以及材料和技术的进步，正在重塑市场格局，并催生出更多针对微创手术特定需求的有效密封剂产品组合。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Johnson & Johnson（United States）
Baxter International Inc.（United States）
Pfizer Inc.（United States）
Integra LifeSciences Corporation（United States）
Smith & Nephew plc（United Kingdom）
B. Braun Melsungen AG（Germany）
CryoLife, Inc.（United States）
CSL Behring（Australia）
Medtronic plc（Ireland）
Zimmer Biomet Holdings, Inc.（United States）
Ferrosan Medical Devices A/S（Denmark）
Cohera Medical, Inc.（United States）
Marine Polymer Technologies, Inc.（United States）
Equimedical BV（Netherlands）
Advanced Medical Solutions Group plc（United Kingdom）
Cohesion Technologies, Inc.（United States）
HyperBranch Medical Technology, Inc.（United States）
Terumo Corporation（Japan）
Mil Laboratories Pvt. Ltd.（India）

结论与建议

简介目录

Product Code: SQMIG35A2694

Global Hemostasis and Tissue Sealing Agents Market size was valued at USD 8.01 Billion in 2024 and is poised to grow from USD 8.66 Billion in 2025 to USD 16.15 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global market for hemostasis and tissue sealing agents is witnessing robust growth, fueled by the increasing incidence of chronic diseases and a rising elderly population, leading to heightened surgical demands. This surge necessitates effective hemostatic and sealing solutions to enhance patient safety and minimize complications. Innovations in surgical procedures, particularly minimally invasive techniques, further stimulate market expansion, with a growing dependence on reliable agents to secure successful outcomes. Manufacturers are prioritizing research and development to create advanced products with enhanced efficacy and fewer side effects, fostering greater acceptance among healthcare professionals. However, challenges persist, including stringent regulatory frameworks, cost constraints, and competitive pressures that impact market dynamics and profitability, necessitating ongoing investment in innovation and strategic positioning.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis and Tissue Sealing Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostasis and Tissue Sealing Agents Market Segments Analysis

Global Hemostasis and Tissue Sealing Agents Market is segmented by Product, Material, Application, End-use and region. Based on Product, the market is segmented into Topical Hemostats and Adhesive & Tissue Sealant. Based on Material, the market is segmented into Gelatin-based Topical Hemostats, Collagen-based Topical Hemostats, ORC-based Topical Hemostats and Polysaccharide-based Topical Hemostats. Based on Application, the market is segmented into General Surgery,Neurosurgery, Vascular Surgery, Cardiovascular Surgery and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemostasis and Tissue Sealing Agents Market

The increasing inclination towards minimally invasive surgical methods has significantly elevated the need for specialized hemostatic and tissue sealing agents, particularly in laparoscopic, endoscopic, and robotic-assisted surgeries. These agents are essential for achieving effective hemostasis and ensuring secure tissue closure, thus enhancing surgical outcomes and patient recovery. As healthcare professionals continue to adopt these advanced surgical techniques, the demand for innovative solutions that support these procedures intensifies, driving the growth of the market for hemostatic and tissue sealing agents. This trend reflects a broader movement towards improving surgical efficiency and patient safety in modern medical practices.

Restraints in the Global Hemostasis and Tissue Sealing Agents Market

The entry of new hemostasis and tissue sealing agents into the market is often impeded by a lengthy and costly approval process, largely driven by stringent regulatory requirements. These rigorous protocols can pose significant challenges for manufacturers, resulting in delays in the commercialization of innovative products. Consequently, the potential for new agents to gain market traction is diminished as they navigate complex regulations, ultimately stifling competition and limiting options for healthcare providers and patients alike. As a result, the overall growth of the global hemostasis and tissue sealing agents market may be adversely affected.

Market Trends of the Global Hemostasis and Tissue Sealing Agents Market

The Global Hemostasis and Tissue Sealing Agents market is increasingly driven by a pronounced shift towards minimally invasive surgical techniques. This trend is propelled by the numerous benefits associated with such procedures, including smaller incisions, reduced scarring, and expedited recovery times. As medical professionals adopt these advanced techniques, the necessity for specialized hemostasis and tissue sealing solutions has surged, fostering innovation in product development. The growing emphasis on patient outcomes, coupled with advancements in materials and technologies, is reshaping the market landscape, resulting in an expanded portfolio of effective sealing agents tailored to the specific needs of minimally invasive surgeries.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Raw Material Analysis

Global Hemostasis and Tissue Sealing Agents Market Size by Product & CAGR (2026-2033)

Market Overview
Topical Hemostats
- Active
- Mechanical
- Flowable
Adhesive & Tissue Sealant
- Synthetic Tissue Sealant
- Natural Tissue Sealant
- Adhesion Barrier Products

Global Hemostasis and Tissue Sealing Agents Market Size by Material & CAGR (2026-2033)

Market Overview
Gelatin-based Topical Hemostats
Collagen-based Topical Hemostats
ORC-based Topical Hemostats
Polysaccharide-based Topical Hemostats

Global Hemostasis and Tissue Sealing Agents Market Size by Application & CAGR (2026-2033)

Market Overview
General Surgery
Neurosurgery
Vascular Surgery
Cardiovascular Surgery
Others

Global Hemostasis and Tissue Sealing Agents Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Others

Global Hemostasis and Tissue Sealing Agents Market Size & CAGR (2026-2033)

North America (Product, Material, Application, End-use)
- US
- Canada
Europe (Product, Material, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Material, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Material, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Material, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Behring (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferrosan Medical Devices A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohera Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Marine Polymer Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Equimedical B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Medical Solutions Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohesion Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HyperBranch Medical Technology, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mil Laboratories Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments